GW791343 3HCl
CAS No. 309712-55-8
GW791343 3HCl( —— )
Catalog No. M17471 CAS No. 309712-55-8
GW791343 HCl is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | Get Quote |
|
| 10MG | 111 | Get Quote |
|
| 25MG | 199 | Get Quote |
|
| 100MG | 768 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGW791343 3HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW791343 HCl is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.
-
DescriptionGW791343 HCl is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.
-
In VitroGW791343 trihydrochloride (0.01, 0.03, 0.1, 0.3, 1, 3, 10 μM; 40 min) shows a non-competitive antagonistic activity to the human P2X7 receptor.GW791343 trihydrochloride (3, 10, 30 μM; 40 min) shows an anegative allosteric modulate activity to the human P2X7 receptor.GW791343 trihydrochloride (5 μM; 24-48 h; ATP measured every 4 h) enhances ATP rhythm in SCN cells. Cell Viability Assay Cell Line:HEK293 cells (expressing human recombinant P2X7 receptors).Concentration:0.01, 0.03, 0.1, 0.3, 1, 3, 10 μM.Incubation Time:40 min (pre-incubate for 10 min and incubate with other P2X7 receptor antagonists for another 30 min).Result:Inhibited agonist-stimulated ethidium accumulation in both sucrose and NaCl buffer.Reduced maximal responses toATP and BzATP in sucrose buffer.Cell Viability Assay Cell Line:HEK293 cells (expressing human recombinant P2X7 receptors).Concentration:3, 10, 30 μM.Incubation Time:40 min (pre-incubate for 10 min and incubate with other P2X7 receptor antagonists for another 30 min).Result:Showed slow reversal effects at the human P2X7 receptor (after 45 min had reversed sufficiently), and had a rapid dissociation rate.Cell Viability Assay Cell Line:SCN cells (from 16-to 21- day-old Wistar rats, which are kept under a controlled 12-12 h light-dark cycle from birth).Concentration:5 μM (replace the medium with fresh drug-containing culture medium every 4 h).Incubation Time:24-48 h (ATP measured every 4 h).Result:Enhanced the amplitude of ATP release rhythm and extracellular ATP accumulation to 144 of control levels.
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorP2X7
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number309712-55-8
-
Formula Weight483.81
-
Molecular FormulaC20H24F2N4O·3HCl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C=C(C=C1)CN2CCNCC2)NC(=O)CNC3=CC(=C(C=C3)F)F.Cl.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Michel AD, et al. Br J Pharmacol. 2009 Apr;156(8):1312-25.
molnova catalog
related products
-
Epigallocatechin
(-)-Epigallocatechin is the most abundant flavonoid in green tea, can bind to unfolded native polypeptides and prevent conversion to amyloid fibrils.
-
CPCCOEt
CPCCOEt is a low-affinity, selective, non-competitive, and reversible antagonist of mGluR1b.
-
SBC-110736
SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor.
Cart
sales@molnova.com